Digest Network Come funziona
Network
/
Società
Ha
Non verificato

Halia Therapeutics

Di cosa scriviamo

AgricolturaEcologia/Salute ambientaleFitnessMedicina - VarieSalute

5 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
15/06/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast (HT-6184) in Lower-Risk Myelodysplastic Syndromes
Fonte
Halia Therapeutics
Emittente
PR News Wire
1.00
0
Press Release cover image
12/05/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
Fonte
Halia Therapeutics
Emittente
PR News Wire
1.00
0
Press Release cover image
02/03/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
Fonte
Halia Therapeutics
Emittente
PR News Wire
1.00
0
04/06/2025
Farmaceutica
Sanità
Biologia
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
Fonte
Halia Therapeutics
Emittente
PR News Wire
1.00
0
29/05/2025
Farmaceutica
Sanità
Finanza
Biologia
Halia Therapeutics CEO Dr. David Bearss to Deliver Keynote Address at Med Investment Forum 2025 in Abu Dhabi
Fonte
Halia Therapeutics
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0